Search Ontology:
ChEBI
elvitegravir
- Term ID
- CHEBI:72289
- Synonyms
-
- 6-(3-chloro-2-fluorobenzyl)-1-[(2S)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
- elvitegravir
- elvitegravirum
- GS 9137
- GS-9137
- Definition
- A quinolinemonocarboxylic acid that is 7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid substited at position 1 by a 1-hydroxy-3-methylbutan-2-yl group and at position 6 by a 3-chloro-2-fluorobenzyl group (the S-enantiomer). It is used in combination therapy for the treatment of HIV-1 infection.
- References
-
- cas:697761-98-1
- drugcentral:4300
- kegg.drug:D06677
- lincs.smallmolecule:LSM-5647
- patent:WO2009089263
- patent:WO2010137032
- patent:WO2011004389
- pubmed:20040702
- pubmed:21044030
- pubmed:21505303
- pubmed:22015077
- pubmed:22197635
- pubmed:22256860
- pubmed:22321026
- pubmed:22347806
- pubmed:22571404
- pubmed:22766666
- pubmed:22789987
- pubmed:22886031
- pubmed:22992351
- pubmed:23028968
- pubmed:23114768
- pubmed:23123342
- pubmed:23136357
- pubmed:23231029
- pubmed:23253887
- pubmed:23337366
- pubmed:23341902
- pubmed:23372110
- reaxys:10609264
- wikipedia.en:Elvitegravir
- Ontology
- ChEBI ( EBI )
Phenotype
Phenotype resulting from elvitegravir
Phenotype where environments contain elvitegravir
Phenotype modified by environments containing elvitegravir
Phenotype affecting elvitegravir
Human Disease Model